What PT-141 is
Bremelanotide is a melanocortin receptor agonist. The FDA-approved product Vyleesi has a specific indication for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder.
What it is not approved for
It is not FDA-approved for erectile dysfunction in men or for general sexual performance enhancement. Compounded men’s programs are outside that approved indication.
What to compare
Exact product, route of administration, dose, pharmacy, clinician oversight, plan length, recurring cost, blood-pressure warnings, nausea risk, and follow-up process.
Matched provider routes
The Telos native destination is a For Men Peptides landing page and belongs on this specialty content. MadeMed includes PT-141 within a compounded combination troche.
Providers worth comparing
These providers belong here because their current care model or destination matches this search intent. Inclusion is not a medical recommendation.
Telos Rx
Best for: People researching clinician-supervised men’s peptide or compounded PT-141 programs
MadeMed
Best for: People specifically comparing compounded combination troches
FeelGood
Best for: People specifically comparing compounded sublingual combination products
MyDrHank
Best for: People comparing a narrow menu of generics and one dissolvable combination
How to use this comparison
- Identify the treatment category and care model you actually want.
- Normalize dose strength, quantity, refill interval, and every recurring fee.
- Read the current provider terms and pharmacy information.
- Give the clinician a complete health and medication history.
- Stop and seek urgent care for warning symptoms described in the prescribing information.